Olimab 60mg Injection

Bonista PF Injection

Price 4850.0 INR / Millimeter

Minimum Order Quantity : 5 Pieces

Drug Type : Injection

Ingredients : Teriparatide Injection is a boneforming medication used to treat osteoporosis in postmenopausal women and men who are at high risk of fractures or who have not responded adequately to other osteoporosis treatments. It works by stimulating new bone growth, increasing bone mineral density, and strengthening bones to reduce the risk of fractures. Available in injection, cartridge, and pen formulations, Teriparatide is administered as a oncedaily subcutaneous injection into the thigh or abdominal area, with or without food, as directed by a healthcare professional. Common side effects may include joint pain, headache, nausea, dizziness, neck pain, constipation, diarrhea, indigestion, vomiting, hypertension, rash, sweating, cough, insomnia, depression, and vertigo. Patients should seek medical attention if they experience injectionsite reactions such as swelling, bruising, itching, or severe allergic symptoms. Teriparatide is not recommended for individuals with an increased risk of bone cancer, including those with Paget s disease, hereditary bone disorders, skeletal malignancies, hypercalcemia, urolithiasis (kidney stones), or orthostatic hypotension. Before starting treatment, patients should inform their doctor about any history of heart disease, bone disorders, kidney problems, or other significant medical conditions. Regular monitoring of blood calcium levels, urine calcium levels, and kidney function may be required during therapy to help ensure safe and effective treatment outcomes.

Storage Instructions : Store at controlled room temperature, between 20 C to 25 C (68 F to 77 F).

Physical Form : Liquid

Infimab 100 Mg Injection

Price 13000.0 INR / Vial

Minimum Order Quantity : 1 Piece

Drug Type : Injection

Ingredients : Infliximab

Storage Instructions : Dry And Cool Place

Physical Form : Liquid

Exemptia 40mg Injection

Price 8000.0 INR / Box

Minimum Order Quantity : 1 Piece

Drug Type : General Medicines

Ingredients : Exemptia 40mg Injection contains Adalimumab, a biologic diseasemodifying antirheumatic drug (DMARD) that belongs to the tumor necrosis factor (TNF) inhibitor class. It is used to treat a variety of autoimmune and inflammatory conditions by reducing inflammation and controlling the overactive immune response that causes tissue damage. Exemptia 40mg Injection is prescribed for conditions such as rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, enthesitisrelated arthritis, ankylosing spondylitis, nonradiographic axial spondyloarthritis, psoriatic arthritis, plaque psoriasis, hidradenitis suppurativa, Crohn s disease, ulcerative colitis, and noninfectious uveitis. By blocking TNF, a key inflammatory protein in the body, this medication helps relieve symptoms such as joint pain, swelling, stiffness, skin lesions, and intestinal inflammation while improving overall quality of life. Exemptia 40mg Injection should not be used in patients who are allergic to Adalimumab, have active tuberculosis, severe infections, or moderate to severe heart failure. Before starting treatment, patients should inform their healthcare provider about any current infections, lung conditions, heart disease, liver or kidney disorders, and all medications they are taking. Women who are pregnant, planning a pregnancy, or breastfeeding should consult their doctor before using this medication. Regular medical monitoring may be recommended during treatment to ensure safety and maximize therapeutic benefits.

Storage Instructions : Dry And Cool Place

Physical Form : Liquid

Adfrar 40mg Injection

Price 6500.0 INR / Pack

Minimum Order Quantity : 5 Packs

Drug Type : Injection

Ingredients : Adfrar 40mg Injection contains Adalimumab, a monoclonal antibody that blocks tumor necrosis factoralpha (TNF ), a key mediator of inflammation in autoimmune diseases. It is used to treat conditions such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, Crohn s disease, and ulcerative colitis by reducing inflammation, pain, swelling, and preventing further joint or tissue damage. Adfrar is administered as a subcutaneous injection, usually once every two weeks, under medical supervision. Common side effects include injectionsite reactions, headache, fatigue, nausea, and mild infections, while serious risks may include severe infections, liver problems, blood disorders, or allergic reactions due to immune suppression. Regular monitoring and immediate medical attention for symptoms like fever, persistent cough, unusual bruising, or yellowing of the skin are essential during treatment.

Physical Form : Liquid